one) and Drug Interactions (seven)]. The risk of hypoglycemia might be lowered by a reduction in the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Advise individuals making use of these concomitant medicines of the potential risk of hypoglycemia and educate them on the signals and signs of hypoglycemia.